Kangmei Pharmaceutical Co., LtdSSE: 600518

Report for Q3 2025

· Issued by Kangmei Pharmaceutical Co., Ltd via Shanghai Stock Exchange

Filed with SSE ·

On 6ix: 6ix.com/news/report-for-q3-2025-83

Report for Q3 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Kangmei Pharmaceutical Co., Ltd on 6ix

Earlier from Kangmei Pharmaceutical

Later from Kangmei Pharmaceutical

All Kangmei Pharmaceutical news releases